-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

721A.O2.6 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Risk Adapted Approaches to Reduce Transplant Related Toxicities

Symposia: Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, AML, Acute Myeloid Malignancies, Adult, Viral, Clinical trials, Translational Research, Elderly, Epidemiology, Clinical Practice (Health Services and Quality), Clinical Research, Pediatric, Education, Supportive Care, Patient-reported outcomes, Diseases, Infectious Diseases, Treatment Considerations, Real-world evidence, Biological therapies, Adverse Events, Myeloid Malignancies, Human, Study Population, Transplantation (Allogeneic and Autologous)
Sunday, December 8, 2024: 4:30 PM-6:00 PM
Room 6B (San Diego Convention Center)
Moderators:
Anna Alperovich, MD, NewYork-Presbyterian/Weill Cornell Medical Center and Mitchell Horwitz, MD, Duke University Medical Center
Disclosures:
Horwitz: Gamida Cell: Consultancy, Speakers Bureau.
4:30 PM

Mohamed Sorror, MD, MSc1,2, Wael Saber, MD, MS3,4, Brent R. Logan, PhD5,6*, Nancy Geller, PhD7*, Anna Bellach, Ph.D.7*, Jianqun Kou, MS6,8*, William A. Wood, MD, MPH9, John M. McCarty, MD10, Thomas G. Knight, MD11, Lyndsey Runaas, MD12*, Laura Johnston, MD13, Jeremy Walston14*, Ryotaro Nakamura, MD15, Asmita Mishra, MD, MBA16, Joseph Uberti, MD, PhD17, Parastoo B Dahi, MD18,19*, Jennifer N. Saultz, DO20, Shannon R McCurdy, MD21, Lawrence E Morris, MD22, Philip Imus, MD23, William J. Hogan, MD24, Kalyan Nadiminti, MBBS25, Vijaya Raj Bhatt, MD26,27, Rebecca Olin, MD28, Joseph E. Maakaron, MD29, Ronald Sobecks, MD30, Sarah A. Wall, MD, MPH31, Deborah Mattila, BA32,33*, Bailey Protz32,33*, Steven Michael Devine, MD33,34, Mary M. Horowitz, MD6,32 and Andrew Artz, MD, MS35

1Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
2Division of Hematology and Oncology, University of Washington School of Medicine, Seattle, WA
3Center for International Blood and Marrow Transplant Research, Minneapolis, MN
4Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI
5Center for International Blood and Marrow Transplant Research (CIBMTR), Milwaukee, WI
6Medical College of Wisconsin, Milwaukee, WI
7National Heart, Lung, and Blood Institute, The Office of Biostatistics Research, Bethesda, MD
8CIBMTR® (Center for International Blood and Marrow Transplant Research), Milwaukee, WI
9Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC
10Virginia Commonwealth University Massey Cancer Center, Richmond, VA
11Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC
12Medical College of Wisconsin, Division of Hematology/Oncology, Milwaukee, WI
13Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA
14Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, MD
15Hematology and HCT, City of Hope National Medical Center, Duarte, CA
16Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
17Karmanos Cancer Institute, Detroit, MI
18Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
19Department of Medicine, Weill Cornell Medical College, New York, NY
20Knight Cancer Institute, Oregon Health & Science University, Portland, OR
21Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
22Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta, GA
23Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
24Division of Hematology, Mayo Clinic, Rochester, MN
25Carbone Cancer Center, University of Wisconsin Hospitals and Clinics, Madison, WI
26Division of Hematology-Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE
27The Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE
28University of California San Francisco, San Francisco, CA
29Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, MN
30Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
31Division of Hematology, The Ohio State University, Columbus, OH
32Center for International Blood and Marrow Transplant Research (CIBMTR), Minneapolis, MN
33National Marrow Donor Program, Minneapolis, MN
34Center for International Blood and Marrow Transplant Research, NMDP, Minneapolis, MN
35City of Hope National Medical Center, Duarte, CA

4:45 PM

Richard J. Lin, MD, PhD1, Soo Jung Kim, NP2*, Samantha Brown3*, Danielle M Hanley1*, Danielle E Engstler1*, Ioannis Politikos, MD4, Boglarka Gyurkocza, MD1, Roni Tamari, MD1, Esperanza B. Papadopoulos, MD1, Amethyst Saldia, BS1*, Yetunde Aremu1*, Aaron D. Goldberg5, Mark Blaine Geyer, MD6, Eytan M. Stein, MD7, Miguel Angel Perales, MD4, Beatriz Korc-Grodzicki, MD, PhD8*, Sean M. Devlin, PhD3* and Sergio A. Giralt, MD1

1Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
4Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
5Department of Medicine; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
6Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
7Department of Medicine; Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY
8Geriatrics Serivce, Memorial Sloan Kettering Cancer Center, New York, NY

5:00 PM

Nihar Desai, MBBS, MD, DM1*, Tommy Alfaro Moya, MD2*, Igor Novitzky-Basso, MD, PhD3,4, Ivan Pasic, MD5,6*, Wilson Lam, MD5,6, Fotios Michelis, MD5,6*, Armin Gerbitz, MD, PhD3,6*, Dennis Dong Hwan Kim, MD, PhD6,7, Auro Viswabandya, MD3,6, Rajat Kumar, MD PhD5,6, Jonas Mattsson, MD, PhD6,8* and Arjun Law, MD6,9

1Princess Margaret Cancer Center, Toronto, ON, Canada
2Princess Margaret Cancer Center, Toronto, Canada
3Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
4Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada
5Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada, Toronto, ON, Canada
6Department of Medicine, University of Toronto, Toronto, ON, Canada
7Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
8Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
9Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada, Toronto, Canada

5:15 PM

Shengling Ma, MD, PhD1, Saleh Bhar2,3, Pavan Bhatraju4*, Mrinal Ranjan, MPH5*, Danielle Guffey, MS6*, Maria Elizabeth Morales7*, Christopher I Amos5*, Caridad Martinez, MD8*, Stephanie J. Lee9*, Sangeeta Hingorani4*, Sarah E Sartain, MD10 and Ang Li, MD, MS5

1Section of Hematology-Oncology, Baylor College of Medicine, HOUSTON, TX
2Baylor College of Medicine, Texas Children's Hospital, Houston, TX
3Texas Children's Cancer & Hematology Centers, Houston, TX
4University of Washington, Seattle, WA
5Baylor College of Medicine, Houston, TX
6Institute for Clinical & Translational Research, Baylor College of Medicine, Houston, TX
7baylor college of medicine, houston
8Baylor College of Medicine, HOUSTON, TX
9Fred Hutchinson Cancer Center, Seattle, WA
10Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine/Texas Children's Hospital, Houston, TX

5:30 PM

Elisabetta Xue, MD1*, Dimana Dimitrova, MD2*, Hyoyoung Choo-Wosoba, PhD3*, Rechache Kamil, MD4*, Ruby Sabina, FNP-BC2*, Christi McKeown, NP2*, Alison Cusmano5*, Mustafa A. Hyder, MD2, Christopher G. Kanakry, MD2 and Jennifer A. Kanakry, MD2*

1Center for Immuno Oncology, National Institute of Health, National Cancer Institute, CHEVY CHASE, MD
2Center for Immuno-Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD
3National Cancer Institute, National Institutes of Health, Bethesda, MD
4Center for Immuno-Oncology/National Cancer Institute, National Institutes of Health, Bethesda, MD
5National Cancer Institute, National Institute of Health, Bethesda, MD

5:45 PM

Xuying Pei, PhD1, Xiaojun Huang2, Zhuojun Liu3*, Qiang Fu4*, Xiaosu Zhao5* and Yuqian Sun6*

1Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
2Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
3Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China
4Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
5Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China
6National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China

*signifies non-member of ASH